Astellas Pharma is a shining star in the Japanese pharmaceuticals market. One of the largest prescription drug companies in Japan, the company’s main products include gastritis treatment Gaster, hypertension therapy Micardis, prostate enlargement treatment Harnal, organ transplant immunosuppressant Prograf, and cholesterol drug Lipitor (sold in Japan via an agreement with Pfizer). Astellas’ products (including those under development) include cardiovascular, central nervous system, oncology, metabolic, infectious disease, inflammation/immunology, gastroenterology, and urology therapies. The company markets its products to health care professionals and consumers in global markets.
Astellas
Unlock to Claim this listing
Add / Modify Company
Click to rate this company
[Total: 0 Average: 0]
Click here to sign in to vote
4.51
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Pharmaceutical ManufacturingESG/Ethical Impact
Astellas’ journey in Killorglin began with a vision to integrate sustainable practices into its core operations. This has led to significant achievements, such as a 98% reduction in CO2 emissions and a 70% reduction in the generation of non-hazardous waste since 2005.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.
Awards Received
2023
Revenues
11418000000
Website Traffic
Employee Rating
3.5
Customer Rating
3.2
Company Size
1000-5000
ESG Risk Rating
4
We’re Happy to Help.
Do you have questions about your ranking, our projects, or why you’re not on the list?





